|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hagan S, Orr MC and Doyle B: Targeted
therapies in colorectal cancer-an integrative view by PPPM. EPMA J.
4:32013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schetter AJ, Okayama H and Harris CC: The
role of microRNAs in colorectal cancer. Cancer J. 18:244–252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nieminen AI, Eskelinen VM, Haikala HM,
Tervonen TA, Yan Y, Partanen JI and Klefström J: Myc-induced
AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial
apoptosis. Proc Natl Acad Sci USA. 110:E1839–E1848. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimizu S, Narita M and Tsujimoto Y: Bcl-2
family proteins regulate the release of apoptogenic cytochrome c by
the mitochondrial channel VDAC. Nature. 399:483–487. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pryczynicz A, Gryko M, Niewiarowska K,
Cepowicz D, Ustymowicz M, Kemona A and Guzińska-Ustymowicz K: Bax
protein may influence the invasion of colorectal cancer. World J
Gastroenterol. 20:1305–1310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
García-Flórez LJ, Gómez-Álvarez G, Frunza
AM, Barneo-Serra L, Martínez-Alonso C and Fresno-Forcelledo MF:
Predictive markers of response to neoadjuvant therapy in rectal
cancer. J Surg Res. 194:120–126. 2015. View Article : Google Scholar
|
|
13
|
Xin M, Li R, Xie M, Park D, Owonikoko TK,
Sica GL, Corsino PE, Zhou J, Ding C, White MA, et al:
Small-molecule Bax agonists for cancer therapy. Nat Commun.
5:49352014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogura E, Senzaki H, Yamamoto D, Yoshida R,
Takada H, Hioki K and Tsubura A: Prognostic significance of Bcl-2,
Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol
Rep. 6:365–369. 1999.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
16
|
Naghdi S, Varnai P and Hajnoczky G: Motifs
of VDAC2 required for mitochondrial Bak import and tBid-induced
apoptosis. Proc Natl Acad Sci USA. 112:E5590–E5599. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Michael MZ, O' Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
18
|
Luo X, Burwinkel B, Tao S and Brenner H:
MicroRNA signatures: Novel biomarker for colorectal cancer? Cancer
Epidemiol Biomarkers Prev. 20:1272–1286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh
T, Kojima K, Nakashima R, Kitade Y and Naoe T: Role of
anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer
Gene Ther. 17:398–408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar
|
|
21
|
Peacock O, Lee AC, Cameron F, Tarbox R,
Vafadar-Isfahani N, Tufarelli C and Lund JN: Inflammation and
MiR-21 pathways functionally interact to downregulate PDCD4 in
colorectal cancer. PloS One. 9:e1102672014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin PL, Wu DW, Huang CC, He TY, Chou MC,
Sheu GT and Lee H: MicroRNA-21 promotes tumour malignancy via
increased nuclear translocation of β-catenin and predicts poor
outcome in APC-mutated but not in APC-wild-type colorectal cancer.
Carcinogenesis. 35:2175–2182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen J, Niu W, Zhou M and Zhang H, Ma J,
Wang L and Zhang H: MicroRNA-410 suppresses migration and invasion
by targeting MDM2 in gastric cancer. PloS One. 9:e1045102014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen N, Wang J, Hu Y, Cui B, Li W, Xu G,
Liu L and Liu S: MicroRNA-410 reduces the expression of vascular
endothelial growth factor and inhibits oxygen-induced retinal
neovascularization. PloS One. 9:e956652014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi SW, Kim JJ, Seo MS, Park SB, Kang TW,
Lee JY, Lee BC, Kang I, Shin TH, Kim HS, et al: miR-410 inhibition
induces RPE differentiation of amniotic epithelial stem cells via
overexpression of OTX2 and RPE65. Stem Cell Rev. 11:376–386. 2015.
View Article : Google Scholar
|
|
26
|
Chien WW, Domenech C, Catallo R, Kaddar T,
Magaud JP, Salles G and Ffrench M: Cyclin-dependent kinase 1
expression is inhibited by p16(INK4a) at the post-transcriptional
level through the microRNA pathway. Oncogene. 30:1880–1891. 2011.
View Article : Google Scholar
|
|
27
|
Chen L, Zhang J, Feng Y, Li R, Sun X, Du
W, Piao X, Wang H, Yang D, Sun Y, et al: MiR-410 regulates MET to
influence the proliferation and invasion of glioma. Int J Biochem
Cell Biol. 44:1711–1717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Fu J, Jiang M, Zhang X, Cheng L,
Xu X, Fan Z, Zhang J, Ye Q and Song H: MiR-410 is overexpressed in
liver and colorectal tumors and enhances tumor cell growth by
silencing FHL1 via a direct/indirect mechanism. PloS One.
9:e1087082014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y and Bodmer WF: Analysis of P53
mutations and their expression in 56 colorectal cancer cell lines.
Proc Natl Acad Sci USA. 103:976–981. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oden-Gangloff A, Di Fiore F, Bibeau F,
Lamy A, Bougeard G, Charbonnier F, Blanchard F, Tougeron D, Ychou
M, Boissière F, et al: TP53 mutations predict disease control in
metastatic colorectal cancer treated with cetuximab-based
chemotherapy. Br J Cancer. 100:1330–1335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo HY and Xu RH: Predictive and
prognostic biomarkers with therapeutic targets in advanced
colorectal cancer. World J Gastroenterol. 20:3858–3874. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baltaziak M, Koda M, Wincewicz A,
Sulkowska M, Kanczuga-Koda L and Sulkowski S: Relationships of P53
and Bak with EPO and EPOR in human colorectal cancer. Anticancer
Res. 29:4151–4156. 2009.PubMed/NCBI
|
|
33
|
Kondo S, Shinomura Y, Miyazaki Y, Kiyohara
T, Tsutsui S, Kitamura S, Nagasawa Y, Nakahara M, Kanayama S and
Matsuzawa Y: Mutations of the bak gene in human gastric and
colorectal cancers. Cancer research. 60:4328–4330. 2000.PubMed/NCBI
|
|
34
|
Krajewska M, Moss SF, Krajewski S, Song K,
Holt PR and Reed JC: Elevated expression of Bcl-X and reduced Bak
in primary colorectal adenocarcinomas. Cancer Res. 56:2422–2427.
1996.PubMed/NCBI
|
|
35
|
Chen X, Liu J, Feng WK, Wu X and Chen SY:
MiR-125b protects against ethanol-induced apoptosis in neural crest
cells and mouse embryos by targeting Bak 1 and PUMA. Exp Neurol.
271:104–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang TC, Wentzel EA, Kent OA,
Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M,
Ferlito M, Lowenstein CJ, et al: Transactivation of miR-34a by p53
broadly influences gene expression and promotes apoptosis. Mol
Cell. 26:745–752. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li
Y, Li Z, Ng SS, Sung JJ, et al: miR-34a-5p suppresses colorectal
cancer metastasis and predicts recurrence in patients with stage
II/III colorectal cancer. Oncogene. 34:4142–4152. 2015. View Article : Google Scholar
|
|
38
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Talotta F, Cimmino A, Matarazzo MR,
Casalino L, De Vita G, D'Esposito M, Di Lauro R and Verde P: An
autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1
activity in RAS transformation. Oncogene. 28:73–84. 2009.
View Article : Google Scholar
|
